Literature DB >> 16390472

An unusual presentation of rhinofacial zygomycosis due to Cunninghamella sp. in an immunocompetent patient: a case report and literature review.

N S S Jayasuriya1, W M Tilakaratne, E A P D Amaratunga, M K B Ekanayake.   

Abstract

Zygomycosis is a rare fungal infection usually found in immunocompromised patients. It is a rapidly progressing infection with a high mortality rate. Our report describes an unusual case of rhinofacial zygomycosis due to Cunninghamella sp. in an immunocompetent patient, who presented with a slowly progressive swelling of the left cheek. An interrupted course of amphotericin B treatment caused regression of the lesion. Drug therapy was abandoned due to impairment of renal function. The patient was clinically and radiologically disease free for 2 years following cessation of therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16390472     DOI: 10.1111/j.1601-0825.2005.01154.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  4 in total

Review 1.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 2.  Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports.

Authors:  Tsung-Ting Hsieh; Hsiang-Kuang Tseng; Pei-Lun Sun; Yu-Hung Wu; Gon-Shen Chen
Journal:  Mycopathologia       Date:  2012-11-04       Impact factor: 2.574

3.  Onychomycosis due to Cunninghamella bertholletiae in an Immunocompetent Male from Central India.

Authors:  Karuna Tadepalli; Pradeep Kumar Gupta; Dinesh P Asati; Debasis Biswas
Journal:  Case Rep Infect Dis       Date:  2015-11-12

4.  Successful treatment of invasive fungal rhinosinusitis caused by Cunninghamella: A case report and review of the literature.

Authors:  Yong-Cai Liu; Min-Li Zhou; Ke-Jia Cheng; Shui-Hong Zhou; Xue Wen; Cheng-Dong Chang
Journal:  World J Clin Cases       Date:  2019-01-26       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.